Immuron (IMRN) Shareholder's Equity (2016 - 2025)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shareholder's Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | 595,226.00 |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | - |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | 14.38 Mn |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | 19.36 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | 31.42 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 1.08 Bn |
| 10 | Immuron | 1.27 Bn | 1.27 Bn | - | 80,318.33 |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 2, 2025 | 80,318.33 |
| Jun 30, 2025 | 5.17 Mn |
| Dec 31, 2024 | 6.76 Mn |
| Sep 9, 2024 | 127,094.44 |
| Jun 30, 2024 | 8.38 Mn |
| Dec 31, 2023 | 114,095.94 |
| Sep 28, 2023 | 12.86 Mn |
| Jun 30, 2023 | 13.11 Mn |
| Dec 31, 2022 | 15.23 Mn |
| Aug 31, 2022 | 16.12 Mn |
| Jun 30, 2022 | 231,774.01 |
| Dec 31, 2021 | 241,776.56 |
| Jun 30, 2021 | 258,950.57 |
| Dec 31, 2020 | 285,406.46 |
| Jun 30, 2020 | 3.70 Mn |
| Dec 31, 2019 | 56,439.13 |
| Jun 30, 2019 | 5.15 Mn |
| Dec 31, 2018 | 7.18 Mn |
| Jun 30, 2018 | 6.39 Mn |
| Dec 31, 2017 | 3.88 Mn |
| Jun 30, 2017 | 4.94 Mn |
| Dec 31, 2016 | 3.73 Mn |